Data from the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) database presented that there were higher HNRNPA2B1 protein levels in breast cancer, OC, colon cancer, and LUAD (Figure 2(c), P < 0.001). This evidence concerns the gene HNRNPA2B1 and malignant colon neoplasm.